{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T16:31:24Z","timestamp":1788107484835,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T00:00:00Z","timestamp":1602633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Guillain-Barr\u00e9 syndrome (GBS) is an autoimmune polyneuropathy affecting the peripheral nervous system. This neurological disorder has been previously reported in bone marrow transplant recipients but is uncommon after kidney transplantation. Viral infections and calcineurin inhibitors are the main triggers of GBS in renal transplant recipients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>In this report, we present a case of a 47-year-old male patient 12 years after his second kidney transplantation who developed GBS due to papillary renal cell carcinoma. Infectious and drug-related origins of GBS were excluded. Despite intensive treatment, graftectomy was performed, after which neurological symptoms resolved.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>In kidney transplant recipients, paraneoplastic aetiology should be considered in the differential diagnosis of GBS.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12882-020-02095-y","type":"journal-article","created":{"date-parts":[[2020,10,14]],"date-time":"2020-10-14T12:03:20Z","timestamp":1602677000000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Guillain-Barre syndrome: a typical paraneoplastic syndrome in a kidney transplant recipient with allograft renal cell carcinoma: a case report and review of the literature"],"prefix":"10.1186","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5251-7763","authenticated-orcid":false,"given":"Izabela","family":"Zakrocka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Baranowicz-G\u0105szczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Korolczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Za\u0142uska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,14]]},"reference":[{"issue":"2","key":"2095_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5114\/fn.2017.68577","volume":"55","author":"PC Piotrowski","year":"2017","unstructured":"Piotrowski PC, Lutkowska A, Tsibulski A, Karczewski M, Jagodzi\u0144ski PP. Neurologic complications in kidney transplant recipients. Folia Neuropathol. 2017;55(2):86\u2013109. https:\/\/doi.org\/10.5114\/fn.2017.68577.","journal-title":"Folia Neuropathol"},{"issue":"1","key":"2095_CR2","doi-asserted-by":"publisher","first-page":"e13021","DOI":"10.1111\/tid.13021","volume":"21","author":"C Ostman","year":"2019","unstructured":"Ostman C, Chacko B. Guillain-Barr\u00e9 syndrome post renal transplant: A systematic review. Transpl Infect Dis. 2019;21(1):e13021. https:\/\/doi.org\/10.1111\/tid.13021.","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"2095_CR3","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1007\/s11255-007-9197-7","volume":"39","author":"SR Keithi-Reddy","year":"2007","unstructured":"Keithi-Reddy SR, Chakravarthi RM, Hussaini SM, Venkatapuram RR, Murthy JM. Cytomegalovirus disease with Guillain-Barr\u00e9 syndrome in a cadaver renal allograft recipient: cause or coincidence. Int Urol Nephrol. 2007;39(3):967\u201370.","journal-title":"Int Urol Nephrol"},{"issue":"3","key":"2095_CR4","doi-asserted-by":"publisher","first-page":"133","DOI":"10.12659\/AOT.883468","volume":"17","author":"A Masajtis-Zagajewska","year":"2012","unstructured":"Masajtis-Zagajewska A, Muras K, Mochecka-Thoelke A, Kurnatowska I, Nowicki M. Guillain-Barr\u00e9 syndrome in the course of EBV infection after kidney transplantation-a case report. Ann Transplant. 2012;17(3):133\u20137.","journal-title":"Ann Transplant"},{"issue":"1","key":"2095_CR5","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2169\/internalmedicine.56.7578","volume":"56","author":"K Nishioka","year":"2017","unstructured":"Nishioka K, Fujimaki M, Kanai K, Ishiguro Y, Nakazato T, Tanaka R, Yokoyama K, Hattori N. Demyelinating peripheral neuropathy due to renal cell carcinoma. Intern Med. 2017;56(1):101\u20134. https:\/\/doi.org\/10.2169\/internalmedicine.56.7578..","journal-title":"Intern Med"},{"issue":"1","key":"2095_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1159\/000458435","volume":"9","author":"I Yang","year":"2017","unstructured":"Yang I, Jaros J, Bega D. Paraneoplastic Peripheral Nervous System Manifestations of Renal Cell Carcinoma: A Case Report and Review of the Literature. Case Rep Neurol. 2017;9(1):22\u201330. https:\/\/doi.org\/10.1159\/000458435..","journal-title":"Case Rep Neurol"},{"issue":"11","key":"2095_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.jiac.2017.04.014","volume":"23","author":"H Koshikawa","year":"2017","unstructured":"Koshikawa H, Tsukie T, Kurita A, Fujikura M, Suzuki M, Araki K. Guillain-Barr\u00e9 syndrome in a patient with renal cell carcinoma following the first course of pazopanib therapy. J Infect Chemother. 2017;23(11):798\u20139. https:\/\/doi.org\/10.1016\/j.jiac.2017.04.014.","journal-title":"J Infect Chemother"},{"issue":"9","key":"2095_CR8","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1097\/00007890-200105150-00023","volume":"71","author":"RA El-Sabrout","year":"2001","unstructured":"El-Sabrout RA, Radovancevic B, Ankoma-Sey V, Van Buren CT. Guillain-Barr\u00e9 syndrome after solid organ transplantation. Transplantation. 2001;71(9):1311\u20136. https:\/\/doi.org\/10.1097\/00007890-200105150-00023.","journal-title":"Transplantation."},{"issue":"2","key":"2095_CR9","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1007\/s15010-015-0819-1","volume":"44","author":"E Shaban","year":"2016","unstructured":"Shaban E, Gohh R, Knoll BM. Late-onset Cytomegalovirus infection complicated by Guillain-Barre syndrome in a kidney transplant recipient: case report and review of the literature. Infection. 2016;44(2):255\u20138. https:\/\/doi.org\/10.1007\/s15010-015-0819-1.","journal-title":"Infection."},{"issue":"1","key":"2095_CR10","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11910-007-0022-6","volume":"7","author":"S Kuwabara","year":"2007","unstructured":"Kuwabara S. Guillain-barr\u00e9 syndrome. Curr Neurol Neurosci Rep. 2007;7(1):57\u201362. https:\/\/doi.org\/10.1007\/s11910-007-0022-6.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"2","key":"2095_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0272-6386(96)90297-8","volume":"28","author":"M Suthanthiran","year":"1996","unstructured":"Suthanthiran M, Morris RE, Strom TB. Immunosuppressants: cellular and molecular mechanisms of action. Am J Kidney Dis. 1996;28(2):159\u201372.","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"2095_CR12","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/ana.410390512","volume":"39","author":"CE Hafer-Macko","year":"1996","unstructured":"Hafer-Macko CE, Sheikh KA, Li CY, Ho TW, Cornblath DR, McKhann GM, Asbury AK, Griffin JW. Immune attack on the Schwann cell surface in acute inflammatory demyelinating polyneuropathy. Ann Neurol. 1996;39(5):625\u201335. https:\/\/doi.org\/10.1002\/ana.410390512.","journal-title":"Ann Neurol"},{"issue":"8","key":"2095_CR13","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1002\/(sici)1097-4598(199708)20:8<1002::aid-mus10>3.0.co;2-x","volume":"20","author":"AI Qureshi","year":"1997","unstructured":"Qureshi AI, Cook AA, Mishu HP, Krendel DA. Guillain-Barr\u00e9 syndrome in Immunocompromised patients: a report of three patients and review of the literature. Muscle Nerve. 1997;20(8):1002\u20137. https:\/\/doi.org\/10.1002\/(sici)1097-4598(199708)20:8<1002::aid-mus10>3.0.co;2-x.","journal-title":"Muscle Nerve"},{"issue":"9","key":"2095_CR14","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1136\/jcp.2004.020354","volume":"58","author":"B Kaya","year":"2005","unstructured":"Kaya B, Davies CE, Oakervee HE, Silver NC, Gawler J, Cavenagh JD. Guillain Barr\u00e9 syndrome precipitated by the use of Antilymphocyte globulin in the treatment of severe aplastic Anaemia. J Clin Pathol. 2005;58(9):994\u20135. https:\/\/doi.org\/10.1136\/jcp.2004.020354.","journal-title":"J Clin Pathol"},{"issue":"1","key":"2095_CR15","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.healun.2005.06.012","volume":"25","author":"JA Falk","year":"2006","unstructured":"Falk JA, Cordova FC, Popescu A, Tatarian G, Criner GJ. Treatment of Guillain-Barr\u00e9 syndrome induced by cyclosporine in a lung transplant patient. J Heart Lung Transplant. 2006;25(1):140\u20133. https:\/\/doi.org\/10.1016\/j.healun.2005.06.012.","journal-title":"J Heart Lung Transplant"},{"key":"2095_CR16","doi-asserted-by":"publisher","unstructured":"Meena P, Bhargava V, Rana DS, Bhalla AK, Gupta A, Malik M, Gupta A, Tiwari V. Tacrolimus-associated Guillain-Barre syndrome. Am J Ther. 2020. https:\/\/doi.org\/10.1097\/MJT.0000000000001096.","DOI":"10.1097\/MJT.0000000000001096"},{"issue":"5","key":"2095_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1055\/s-2007-1000693","volume":"59","author":"W M\u00fcllges","year":"1991","unstructured":"M\u00fcllges W, Ringelstein EB, Sommer C, Biniek R, Gl\u00f6ckner WM. Immunotherapy of chronic Guillain-Barr\u00e9 syndrome with high dose IgG and cyclosporin a. case report, review of the literature and perspectives. Fortschr Neurol Psychiatr. 1991;59(5):183\u20139.","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"4","key":"2095_CR18","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/(SICI)1097-4598(199804)21:4<454::AID-MUS3>3.0.CO;2-8","volume":"21","author":"MH Barnett","year":"1998","unstructured":"Barnett MH, Pollard JD, Davies L, McLeod JG. Cyclosporin a in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1998;21(4):454\u201360.","journal-title":"Muscle Nerve"},{"key":"2095_CR19","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.ensci.2016.08.001","volume":"4","author":"T Yoshida","year":"2016","unstructured":"Yoshida T, Ueki Y, Suzuki T, Kawagashira Y, Koike H, Kusumoto S, Ida S, Oguri T, Omura M, Sobue MN. Guillain-Barr\u00e9 syndrome after allogeneic bone marrow transplantation: case report and literature review. eNeurologicalSci. 2016;4:52\u20135. https:\/\/doi.org\/10.1016\/j.ensci.2016.08.001.","journal-title":"eNeurologicalSci."},{"issue":"3","key":"2095_CR20","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1016\/j.nmd.2010.11.004","volume":"21","author":"JA Allen","year":"2011","unstructured":"Allen JA, Yang XJ, Sufit RL. Reversible demyelinating neuropathy associated with renal cell carcinoma. Neuromuscul Disord. 2011;21(3):227\u201331.","journal-title":"Neuromuscul Disord"},{"issue":"1","key":"2095_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000163053","volume":"18","author":"HM Turk","year":"2009","unstructured":"Turk HM, Ozet A, Kuzhan O, Komurcu F, Arpaci F, Ozturk B, Ataergin S. Paraneoplastic motor neuron disease resembling amyotrophic lateral sclerosis in a patient with renal cell carcinoma. Med Princ Pract. 2009;18(1):73\u20135.","journal-title":"Med Princ Pract"},{"key":"2095_CR22","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1093\/milmed\/167.12.986","volume":"167","author":"MJ Roy","year":"2002","unstructured":"Roy MJ, May EF, Jabbari B. Life-threatening polyneuropathy heralding renal cell carcinoma. Mil Med. 2002;167:986\u20139.","journal-title":"Mil Med"},{"issue":"8","key":"2095_CR23","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1016\/S0002-9343(03)00125-6","volume":"114","author":"A Alimonti","year":"2003","unstructured":"Alimonti A, Di Cosimo S, Di Stani F, Vecchione A, Di Palma M, Ferretti G. Subacute motor weakness and left renal mass. Am J Med. 2003;114(8):706\u20138.","journal-title":"Am J Med"},{"issue":"3","key":"2095_CR24","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1378\/chest.115.3.899","volume":"115","author":"D Forman","year":"1999","unstructured":"Forman D, Rae-Grant AD, Matchett SC, Cowen JS. A reversible cause of hypercapnic respiratory failure: lower motor neuronopathy associated with renal cell carcinoma. Chest. 1999;115(3):899\u2013901.","journal-title":"Chest."},{"issue":"2","key":"2095_CR25","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3346\/jkms.1992.7.2.167","volume":"7","author":"JS Kim","year":"1992","unstructured":"Kim JS, Cho JH. Progressive atypical peripheral neuropathy following nephrectomy in a patient with renal cell carcinoma. J Korean Med Sci. 1992;7(2):167\u20139.","journal-title":"J Korean Med Sci"},{"issue":"6","key":"2095_CR26","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1212\/WNL.40.6.960","volume":"40","author":"BK Evans","year":"1990","unstructured":"Evans BK, Fagan C, Arnold T, Dropcho EJ, Oh SJ. Paraneoplastic motor neuron disease and renal cell carcinoma: improvement after nephrectomy. Neurology. 1990;40(6):960\u20132.","journal-title":"Neurology."},{"issue":"4","key":"2095_CR27","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1111\/j.1468-1331.2006.01254.x","volume":"13","author":"S Gentile","year":"2006","unstructured":"Gentile S, Messina M, Rainero I, Lo Giudice R, De Martino P, Pinessi L. Miller fisher syndrome associated with Burkitt's lymphoma. Eur J Neurol. 2006;13(4):430.","journal-title":"Eur J Neurol"},{"issue":"20","key":"2095_CR28","first-page":"30945","volume":"S0090\u20134295","author":"S Jiang","year":"2020","unstructured":"Jiang S, Regmi S, Jackson S, Calvert C, Jarosek S, Pruett T, Warlick C. Risk of genitourinary malignancy in the renal transplant patient. Urology. 2020;S0090\u20134295(20):30945\u20136.","journal-title":"Urology"},{"issue":"8","key":"2095_CR29","doi-asserted-by":"publisher","first-page":"3046","DOI":"10.1016\/j.transproceed.2009.07.090","volume":"41","author":"A Kolonko","year":"2009","unstructured":"Kolonko A, Pinocy-Ma\u0144dok J, Kocierz M, Kujawa-Szewieczek A, Chudek J, Malyszko J, Malyszko JS, My\u015bliwiec M, Wiecek A. Anemia and erythrocytosis after kidney transplantation: a 5-year graft function and survival analysis. Transplant Proc. 2009;41(8):3046\u201351.","journal-title":"Transplant Proc"},{"issue":"10","key":"2095_CR30","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1111\/j.1432-2277.2012.01513.x","volume":"25","author":"J Malyszko","year":"2012","unstructured":"Malyszko J, Oberbauer R, Watschinger B. Anemia and erythrocytosis in patients after kidney transplantation. Transpl Int. 2012;25(10):1013\u201323.","journal-title":"Transpl Int"},{"issue":"4","key":"2095_CR31","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1046\/j.1523-1755.2003.00850.x","volume":"63","author":"DV Vlahakos","year":"2003","unstructured":"Vlahakos DV, Marathias KP, Agroyannis B, Madias NE. Posttransplant erythrocytosis. Kidney Int. 2003;63(4):1187\u201394.","journal-title":"Kidney Int"},{"issue":"2","key":"2095_CR32","doi-asserted-by":"publisher","first-page":"154","DOI":"10.5414\/cn107107","volume":"79","author":"MM Javaid","year":"2013","unstructured":"Javaid MM, Chowdhury S, Henderson A, Olsburgh J. Advanced Native Kidney Renal Cell Carcinoma in Renal Transplant Recipients: Role of Sirolimus as Dual Anti-Cancer and Anti-Rejection Agent. Clin Nephrol. 2013;79(2):154\u201360. https:\/\/doi.org\/10.5414\/cn107107.","journal-title":"Clin Nephrol"},{"issue":"8","key":"2095_CR33","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1016\/j.transproceed.2017.06.035","volume":"49","author":"A Billis","year":"2017","unstructured":"Billis A, Freitas LLL, Costa LBE, Barreto IS, Asato MA, Araujo KS, Losada DM, Herculiani AP, Tabosa GVBS, Zaidan BC, Oliveira GLP, Bastos LQA, Rocha RM. Genitourinary malignancies in transplant or Dialysis patients: the frequency of two newly described 2016 World Health Organization Histopathologic types. Transplant Proc. 2017;49(8):1783\u20135. https:\/\/doi.org\/10.1016\/j.transproceed.2017.06.035.","journal-title":"Transplant Proc"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02095-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-020-02095-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-020-02095-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T23:45:29Z","timestamp":1634168729000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-020-02095-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,14]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2095"],"URL":"https:\/\/doi.org\/10.1186\/s12882-020-02095-y","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,14]]},"assertion":[{"value":"27 May 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient. A copy of the consent form is available for review and can be provided on request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"434"}}